[Information] High-performance solutions for CAR-T development

In recent years, advancements in assay technology have begun to significantly change the drug discovery and development of CAR-T!

Chimeric antigen receptor T cell (CAR-T) therapy uses genetically modified T cells to fight cancer and holds the potential to revolutionize the medical landscape. However, it is challenging for researchers developing cell-based therapies to explore the complex immune system, especially when using traditional screening and profiling methods. Recently, advancements in assay technology have begun to significantly change the drug discovery and development of CAR-T. These technological advancements have enabled high-throughput, cost-effective analyses that provide speed and sensitivity, yielding deeper biologically relevant information and allowing for the rapid acquisition of practical results. *You can download the English version of the catalog. *For more details, please refer to the PDF materials or feel free to contact us.

others